Success Stories

Prof. Shabtay Dikstein of the School of Pharmacy at the Faculty of Medicine has developed two medical products: Eyecon, an eye drop therapy for dry eye and conjunctival damage even in severe cases, which is manufactured by Excelvision (France) and Pharma Stulln (Germany); and Silkis, a non-steroidal ointment for the treatment of psoriasis, which is produced by Galderma (France).

Prof. Avi Domb, the Lionel Jacobson Professor of Medicinal Chemistry, of the School of Pharmacy at the Faculty of Medicine developed the MAZE – Water Purification System, a new type of filter that is installed in portable water purification systems and is capable of purifying water from organic and inorganic toxic residues as well as bacteria and viruses. The filter and water purification system are manufactured by Strauss-Haier (China).

Prof. Michael Friedman (center), the Adolph D. and Horty Storch Professor of Pharmaceutical Sciences, of the School of Pharmacy at the Faculty of Medicine, Prof. Michael Sela (right), the Betty and D. Walter Cohen Professor of Clinical Periodontal Research, Prof. Doron Steinberg (left) and Prof. Aubrey Soskolne of the Faculty of Dental Medicine, developed PerioChip, a degradable sustained release delivery system for the treatment of periodontal disease through the release of an antibacterial agent into the periodontal pockets. PerioChip is manufactured and distributed worldwide by Dexcel Pharma (Israel).

Prof. Elka Touitou of the School of Pharmacy at the Faculty of Medicine invented the Ethosome, a novel nanotechnology for skin drug delivery. The Ethosomal carrier is used in the design of efficient pharmaceutical and cosmetic products for the treatment of various skin ailments. Two products based on the invention have been developed to date: Supra-Vir, for treating herpes of the lips, which is manufactured by Trima (Israel); and Body Shape, a dermo cosmetic gel for the treatment of cellulite, which is manufactured by NTT – Novel Therapeutic Technologies (Israel).

Prof. Marta Weinstock-Rosin, the Dr. Leon Deutsch and Dr. Mina Deutsch Professor of Psychopharmacology, of the School of Pharmacy at the Faculty of Medicine, developed Exelon, a medicine prescribed for people with mild to moderate Alzheimer's disease. Exelon can slow the progression of the disease in a significant proportion of patients and improve cognitive function in some subjects. Exelon is manufactured by Novartis (Switzerland).